SCHEMBL328930

SCHEMBL328930

COP(=O)(CP(=O)(OC)OC)OC

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14827466 0.83
SCHEMBL10395299 0.83 TSHR (0.55) TSHR
SCHEMBL10395216 0.83 TSHR (0.55) TSHR
SCHEMBL7647258 0.81 KDM4E (0.50)
SCHEMBL8172845 0.81 CTSA (0.40)
SCHEMBL14790677 0.81
SCHEMBL10395275 0.81 CTSA (0.40)
SCHEMBL10395212 0.79 MEN1 (0.36) TSHR
SCHEMBL9192261 0.78 KDM4E (0.33)
SCHEMBL17228536 0.78 TSHR (0.57) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260081229-A1 ELECTROLYTIC SOLUTION AND BATTERY GUANGZHOU TINCI MATERIALS TECH CO LTD (CN) 2026-03-19 US claimed
EP-4708442-A1 ELECTROLYTE AND BATTERY Guangzhou Tinci Materials Technology Co., Ltd. (CN) 2026-03-11 EP claimed
US-20250279473-A1 ELECTROLYTE FOR LITHIUM IRON PHOSPHATE BATTERY, AND LITHIUM IRON PHOSPHATE BATTERY GUANGZHOU TINCI MATERIALS TECHNOLOGY CO., LTD. (CN) 2025-09-04 US claimed
US-20250266502-A1 LITHIUM-ION BATTERY ELECTROLYTIC SOLUTION, LITHIUM-ION BATTERY, AND METHOD FOR IMPROVING BATTERY PERFORMANCE Guangzhou Tinci Materials Technology Co., Ltd (CN) 2025-08-21 US claimed
CN-114891038-A Phosphoantigen compound, method for producing the same, and culture method for Vgamma 9 Vdelta 2T cells 珠海善行免疫微生态产业研究院有限公司 2022-08-12 CN claimed
US-20170275314-A1 ALKYLIDENE PHOSPHONATE ESTERS AS P-GLYCOPROTEIN INDUCERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-09-28 US claimed
EP-3209671-A1 ALKYLIDENE PHOSPHONATE ESTERS AS P-GLYCOPROTEIN INDUCERS Council of Scientific and Industrial Research (IN) 2017-08-30 EP claimed
EP-2578563-B1 INTERMEDIATE OF LYCOPENE AND PREPARATION METHOD OF INTERMEDIATE THEREOF UNIV SHAOXING (CN) 2015-03-18 EP claimed
EP-2578564-B1 PREPARATION METHOD OF AN INTERMEDIATE FOR THE PREPARATION OF LYCOPENE UNIV SHAOXING (CN) 2015-03-11 EP claimed
US-8697918-B2 Intermediate of lycopene and preparation method of intermediate SHAOXING UNIVERSITY (CN) 2014-04-15 US claimed
US-20140005434-A1 INTERMEDIATE OF LYCOPENE AND PREPARATION METHOD OF INTERMEDIATE THEREOF SHAOXING UNIVERSITY (CN) 2014-01-02 US claimed
US-20140005442-A1 INTERMEDIATE OF LYCOPENE AND PREPARATION METHOD OF INTERMEDIATE SHAOXING UNIVERSITY (CN) 2014-01-02 US claimed
EP-2578564-A1 INTERMEDIATE OF LYCOPENE AND PREPARATION METHOD OF INTERMEDIATE Shaoxing University (CN) 2013-04-10 EP claimed
EP-2578563-A1 INTERMEDIATE OF LYCOPENE AND PREPARATION METHOD OF INTERMEDIATE THEREOF Shaoxing University (CN) 2013-04-10 EP claimed
EP-0221611-A2 Antimicrobial agents and process for their manufacture THE PROCTER & GAMBLE COMPANY (US) 1987-05-13 EP claimed
EP-3772130-B1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTIONS, NON-AQUEOUS ELECTROLYTE SOLUTION, AND ELECTRICITY STORAGE DEVICE SUMITOMO SEIKA CHEMICALS (JP) 2026-05-06 EP disclosed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
US-4141967-A ANHYDROUS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 1979-02-27 US disclosed
EP-0000024-A1 Polyadducts containing phosphorus and their application in the flameproofing of textile materials HOECHST AKTIENGESELLSCHAFT (DE) 1978-12-20 EP disclosed
US-4032521-A ANTIBIOTICS MERCK & CO., INC. (US) 1977-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260081229-A1 ELECTROLYTIC SOLUTION AND BATTERY NHERF1, CLIC4, SLC10A6 TSHR 2694/4885
US-20140005434-A1 INTERMEDIATE OF LYCOPENE AND PREPARATION METHOD OF INTERMEDIATE THEREOF ALOX5, ALOX15, ALOX12 TSHR 3969/4885
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 TSHR 2348/4885
US-20140005442-A1 INTERMEDIATE OF LYCOPENE AND PREPARATION METHOD OF INTERMEDIATE ALOX5, ELOVL3, ELOVL5 TSHR 3852/4885
US-20170275314-A1 ALKYLIDENE PHOSPHONATE ESTERS AS P-GLYCOPROTEIN INDUCERS ABCB1, ABCC2, ABCC4 TSHR 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.